4.7 Review

Contemporary Fertility-Sparing Management Options of Early Stage Endometrioid Endometrial Cancer in Young Nulliparous Patients

Journal

JOURNAL OF CLINICAL MEDICINE
Volume 11, Issue 1, Pages -

Publisher

MDPI
DOI: 10.3390/jcm11010196

Keywords

endometrial cancer; young nulliparous patient; fertility-sparing therapy; hormonal treatment; endometrial cancer and fertility; pregnancy after fertility-sparing therapy

Funding

  1. Nazarbayev University [110119FD4540]
  2. [2019-2021]

Ask authors/readers for more resources

Incidence of endometrial cancer has been increasing in recent years, especially in high-income countries. Fertility-sparing treatment for young patients with EC has become extremely important due to increasing incidence among reproductive age women. Several fertility-sparing options, including medication, minimally invasive surgical techniques, and the utilization of molecular biomarkers, have been developed and found to be efficient for fertility preservation.
Incidence of endometrial cancer (EC) has been increasing in recent years, especially in high-income countries. The disease commonly affects peri- and postmenopausal women; however, about 5% of women are diagnosed with EC in their reproductive age. Due to both the increasing incidence of EC among reproductive age women and trends to delayed childbearing, fertility-sparing treatment for young patients with EC has become extremely important for researchers and practitioners. Because the classic treatment with total hysterectomy and bilateral saplingo-oophorectomy is not an appropriate approach for young women demanding fertility preservation, several fertility-sparing options have been developed and summarized in this review. Utilization of different medications and their combination (progestagens, gonadotropin releasing hormones analogues, and metformin in different formulations) are tested and found as efficient for fertility-sparing treatment. New minimally invasive surgical techniques, combined with progestagens, are also confirmed as valuable. There are many novel conservative and surgical treatment approaches under investigation. Assuming that molecular biomarkers can be both diagnostic and prognostic to assist in prediction of response to a certain therapy, prognostic risk groups' stratification along with specific biomarkers' identification will ensure low recurrence and decrease mortality rates in young women with EC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available